More on AMGN
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $354.06 |
|
|||
| Open | $357.39 | ||||
| 52 Wk High | $176.85 | ||||
| 52 Wk Low | $133.64 | ||||
| Day High | $358.17 | ||||
| Day Low | $351.96 | ||||
| P/E | 53.49 | ||||
| EPS | $6.64 | ||||
| Volume | 2,730,230 | ||||
- Piper Sandler Reiterates Overweight Rating on Amgen (AMGN)
- Form 11-K AMGEN INC For: Dec 31
- Form 11-K AMGEN INC For: Dec 31
- Amgen (AMGN) PT Raised to $340 at Morgan Stanley
- AMGEN's Repatha shows 29% cardiovascular event reduction in diabetes study
- AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
- AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
- AMGEN presents data on rare disease drugs at european medical congress
- AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
- AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
Entities mentioned with AMGN
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- Dividend | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
